Published in J Virol on August 01, 2006
PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. J Virol (2006) 3.03
The control of viral infection by tripartite motif proteins and cyclophilin A. Retrovirology (2007) 2.54
PML nuclear bodies. Cold Spring Harb Perspect Biol (2010) 2.44
Replication of ICP0-null mutant herpes simplex virus type 1 is restricted by both PML and Sp100. J Virol (2007) 1.95
Herpes simplex virus type 1 genomes are associated with ND10 nuclear substructures in quiescently infected human fibroblasts. J Virol (2007) 1.65
The intracellular DNA sensor IFI16 gene acts as restriction factor for human cytomegalovirus replication. PLoS Pathog (2012) 1.64
Nuclear domain 10 components promyelocytic leukemia protein and hDaxx independently contribute to an intrinsic antiviral defense against human cytomegalovirus infection. J Virol (2007) 1.61
Human cytomegalovirus gene expression is silenced by Daxx-mediated intrinsic immune defense in model latent infections established in vitro. J Virol (2007) 1.60
An active TRIM5 protein in rabbits indicates a common antiviral ancestor for mammalian TRIM5 proteins. J Virol (2007) 1.54
Retracted Sp100 as a potent tumor suppressor: accelerated senescence and rapid malignant transformation of human fibroblasts through modulation of an embryonic stem cell program. Cancer Res (2010) 1.46
Cellular promyelocytic leukemia protein is an important dengue virus restriction factor. PLoS One (2015) 1.38
The intrinsic antiviral defense to incoming HSV-1 genomes includes specific DNA repair proteins and is counteracted by the viral protein ICP0. PLoS Pathog (2011) 1.37
Human cytomegalovirus protein pp71 displaces the chromatin-associated factor ATRX from nuclear domain 10 at early stages of infection. J Virol (2008) 1.36
PML isoforms I and II participate in PML-dependent restriction of HSV-1 replication. J Cell Sci (2010) 1.35
SUMO pathway dependent recruitment of cellular repressors to herpes simplex virus type 1 genomes. PLoS Pathog (2011) 1.30
Cellular and viral control over the initial events of human cytomegalovirus experimental latency in CD34+ cells. J Virol (2010) 1.29
Binding STAT2 by the acidic domain of human cytomegalovirus IE1 promotes viral growth and is negatively regulated by SUMO. J Virol (2008) 1.25
Cellular proteins PML and Daxx mediate an innate antiviral defense antagonized by the adenovirus E4 ORF3 protein. J Virol (2008) 1.22
Specification of the NF-kappaB transcriptional response by p65 phosphorylation and TNF-induced nuclear translocation of IKK epsilon. Nucleic Acids Res (2010) 1.20
Genome-wide screen of three herpesviruses for protein subcellular localization and alteration of PML nuclear bodies. PLoS Pathog (2008) 1.20
Human cytomegalovirus persistence. Cell Microbiol (2012) 1.16
Components of promyelocytic leukemia nuclear bodies (ND10) act cooperatively to repress herpesvirus infection. J Virol (2012) 1.16
Novel mode of phosphorylation-triggered reorganization of the nuclear lamina during nuclear egress of human cytomegalovirus. J Biol Chem (2010) 1.14
Differential Roles of PML Isoforms. Front Oncol (2013) 1.13
Adenovirus E4 ORF3 protein inhibits the interferon-mediated antiviral response. J Virol (2007) 1.11
Entrapment of viral capsids in nuclear PML cages is an intrinsic antiviral host defense against varicella-zoster virus. PLoS Pathog (2011) 1.10
Murine gammaherpesvirus 68 open reading frame 75c tegument protein induces the degradation of PML and is essential for production of infectious virus. J Virol (2008) 1.10
Human cytomegalovirus infection causes degradation of Sp100 proteins that suppress viral gene expression. J Virol (2011) 1.09
STAT-1- and IRF-3-dependent pathways are not essential for repression of ICP0-null mutant herpes simplex virus type 1 in human fibroblasts. J Virol (2008) 1.09
Epstein-Barr virus nuclear antigen 1 Hijacks the host kinase CK2 to disrupt PML nuclear bodies. J Virol (2010) 1.08
Components of nuclear domain 10 bodies regulate varicella-zoster virus replication. J Virol (2009) 1.07
Functions of the Epstein-Barr virus EBNA1 protein in viral reactivation and lytic infection. J Virol (2012) 1.03
Interplay between Herpesvirus Infection and Host Defense by PML Nuclear Bodies. Viruses (2009) 1.03
Evidence for a dual antiviral role of the major nuclear domain 10 component Sp100 during the immediate-early and late phases of the human cytomegalovirus replication cycle. J Virol (2011) 1.03
Regulation of the retinoblastoma proteins by the human herpesviruses. Cell Div (2009) 1.02
Functional reorganization of promyelocytic leukemia nuclear bodies during BK virus infection. MBio (2011) 1.02
The co-chaperone BAG3 regulates Herpes Simplex Virus replication. Proc Natl Acad Sci U S A (2008) 1.01
Proteomic profiling of the human cytomegalovirus UL35 gene products reveals a role for UL35 in the DNA repair response. J Virol (2011) 1.01
Cyclin-dependent kinase activity controls the onset of the HCMV lytic cycle. PLoS Pathog (2010) 1.00
Recruitment of human cytomegalovirus immediate-early 2 protein onto parental viral genomes in association with ND10 in live-infected cells. J Virol (2007) 0.99
Tegument protein control of latent herpesvirus establishment and animation. Herpesviridae (2011) 0.98
Promyelocytic leukemia-nuclear body proteins: herpesvirus enemies, accomplices, or both? Future Virol (2008) 0.98
Chromatin-mediated regulation of cytomegalovirus gene expression. Virus Res (2010) 0.97
Herpesvirus saimiri antagonizes nuclear domain 10-instituted intrinsic immunity via an ORF3-mediated selective degradation of cellular protein Sp100. J Virol (2012) 0.96
Differences between mouse and human cytomegalovirus interactions with their respective hosts at immediate early times of the replication cycle. Med Microbiol Immunol (2008) 0.96
PML promotes MHC class II gene expression by stabilizing the class II transactivator. J Cell Biol (2012) 0.95
Reversal of heterochromatic silencing of quiescent herpes simplex virus type 1 by ICP0. J Virol (2010) 0.95
Sp100 provides intrinsic immunity against human papillomavirus infection. MBio (2013) 0.95
Physical requirements and functional consequences of complex formation between the cytomegalovirus IE1 protein and human STAT2. J Virol (2009) 0.95
DNA virus replication compartments. J Virol (2013) 0.94
Functional connection between Rad51 and PML in homology-directed repair. PLoS One (2011) 0.92
Human embryonic stem cell lines model experimental human cytomegalovirus latency. MBio (2013) 0.92
Expression pattern and subcellular localization of human papillomavirus minor capsid protein L2. Am J Pathol (2008) 0.92
Positive role of promyelocytic leukemia protein in type I interferon response and its regulation by human cytomegalovirus. PLoS Pathog (2015) 0.91
Virus-induced aggregates in infected cells. Viruses (2012) 0.91
Crystal structure of cytomegalovirus IE1 protein reveals targeting of TRIM family member PML via coiled-coil interactions. PLoS Pathog (2014) 0.91
Human cytomegalovirus infection of human embryonic stem cell-derived primitive neural stem cells is restricted at several steps but leads to the persistence of viral DNA. J Virol (2014) 0.91
Kaposi's sarcoma associated herpesvirus tegument protein ORF75 is essential for viral lytic replication and plays a critical role in the antagonization of ND10-instituted intrinsic immunity. PLoS Pathog (2014) 0.91
Human cytomegalovirus IE72 protein interacts with the transcriptional repressor hDaxx to regulate LUNA gene expression during lytic infection. J Virol (2010) 0.90
The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. Mol Syst Biol (2015) 0.90
The tumor suppressor PML specifically accumulates at RPA/Rad51-containing DNA damage repair foci but is nonessential for DNA damage-induced fibroblast senescence. Mol Cell Biol (2014) 0.90
Human cytomegalovirus protein pp71 induces Daxx SUMOylation. J Virol (2009) 0.90
Myeloblastic cell lines mimic some but not all aspects of human cytomegalovirus experimental latency defined in primary CD34+ cell populations. J Virol (2013) 0.89
Insertion of an EYFP-pp71 (UL82) coding sequence into the human cytomegalovirus genome results in a recombinant virus with enhanced viral growth. J Virol (2008) 0.89
Post-Translational Modifications of Kaposi's Sarcoma-Associated Herpesvirus Regulatory Proteins - SUMO and KSHV. Front Microbiol (2012) 0.89
Arsenic trioxide inhibits hepatitis C virus RNA replication through modulation of the glutathione redox system and oxidative stress. J Virol (2008) 0.89
DNA sensing-independent inhibition of herpes simplex virus 1 replication by DAI/ZBP1. J Virol (2013) 0.89
The spatial organization of DNA virus genomes in the nucleus. PLoS Pathog (2013) 0.89
Origin and diversification of TRIM ubiquitin ligases. PLoS One (2012) 0.88
Herpes simplex virus is equipped with RNA- and protein-based mechanisms to repress expression of ATRX, an effector of intrinsic immunity. J Virol (2012) 0.88
Biphasic recruitment of transcriptional repressors to the murine cytomegalovirus major immediate-early promoter during the course of infection in vivo. J Virol (2010) 0.87
Contribution of the Major ND10 Proteins PML, hDaxx and Sp100 to the Regulation of Human Cytomegalovirus Latency and Lytic Replication in the Monocytic Cell Line THP-1. Viruses (2015) 0.87
Histone deacetylases in herpesvirus replication and virus-stimulated host defense. Viruses (2013) 0.87
Mutations in the M112/M113-coding region facilitate murine cytomegalovirus replication in human cells. J Virol (2010) 0.86
The human cytomegalovirus major immediate-early proteins as antagonists of intrinsic and innate antiviral host responses. Viruses (2009) 0.86
CTCF binding to the first intron of the major immediate early (MIE) gene of human cytomegalovirus (HCMV) negatively regulates MIE gene expression and HCMV replication. J Virol (2014) 0.86
The replication defect of ICP0-null mutant herpes simplex virus 1 can be largely complemented by the combined activities of human cytomegalovirus proteins IE1 and pp71. J Virol (2012) 0.86
Reversible silencing of cytomegalovirus genomes by type I interferon governs virus latency. PLoS Pathog (2014) 0.85
The potential link between PML NBs and ICP0 in regulating lytic and latent infection of HSV-1. Protein Cell (2012) 0.85
Analysis of human cytomegalovirus-encoded SUMO targets and temporal regulation of SUMOylation of the immediate-early proteins IE1 and IE2 during infection. PLoS One (2014) 0.84
Anti-tumour effects of small interfering RNA targeting anion exchanger 1 in experimental gastric cancer. Br J Pharmacol (2012) 0.84
Complementation of a herpes simplex virus ICP0 null mutant by varicella-zoster virus ORF61p. J Virol (2009) 0.83
Regulation of human cytomegalovirus transcription in latency: beyond the major immediate-early promoter. Viruses (2013) 0.83
Impact of Adenovirus E4-ORF3 Oligomerization and Protein Localization on Cellular Gene Expression. Viruses (2015) 0.82
Murine gammaherpesvirus 68 ORF75c contains ubiquitin E3 ligase activity and requires PML SUMOylation but not other known cellular PML regulators, CK2 and E6AP, to mediate PML degradation. Virology (2013) 0.82
Cellular defense against latent colonization foiled by human cytomegalovirus UL138 protein. Sci Adv (2015) 0.81
Functional interaction of nuclear domain 10 and its components with cytomegalovirus after infections: cross-species host cells versus native cells. PLoS One (2011) 0.81
Different subcellular localisations of TRIM22 suggest species-specific function. Immunogenetics (2009) 0.81
Deletion of the rat cytomegalovirus immediate-early 1 gene results in a virus capable of establishing latency, but with lower levels of acute virus replication and latency that compromise reactivation efficiency. J Gen Virol (2009) 0.81
The mouse cytomegalovirus immediate-early 1 gene is not required for establishment of latency or for reactivation in the lungs. J Virol (2009) 0.81
HSV-I and the cellular DNA damage response. Future Virol (2015) 0.81
Nuclear domain 10 of the viral aspect. World J Virol (2013) 0.80
Promyelocytic leukemia protein modulates establishment and maintenance of latent gammaherpesvirus infection in peritoneal cells. J Virol (2013) 0.80
H2B homology region of major immediate-early protein 1 is essential for murine cytomegalovirus to disrupt nuclear domain 10, but is not important for viral replication in cell culture. J Gen Virol (2011) 0.79
Immediate-Early (IE) gene regulation of cytomegalovirus: IE1- and pp71-mediated viral strategies against cellular defenses. Virol Sin (2014) 0.78
Nuclear domain 10-associated proteins recognize and segregate intranuclear DNA/protein complexes to negate gene expression. Virol J (2012) 0.78
Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat Biotechnol (2004) 36.25
Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell (1991) 9.40
The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell (1991) 8.98
Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain. Proc Natl Acad Sci U S A (2005) 6.85
PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol (1999) 5.83
Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J (1998) 5.15
Intrinsic immunity: a front-line defense against viral attack. Nat Immunol (2004) 4.95
TRIM family proteins: retroviral restriction and antiviral defence. Nat Rev Microbiol (2005) 4.89
The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms. J Virol (1998) 4.43
Something about SUMO inhibits transcription. Curr Opin Genet Dev (2005) 4.05
Role of SUMO-1-modified PML in nuclear body formation. Blood (2000) 4.05
The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition. J Cell Biol (1996) 3.91
A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies. J Cell Sci (1992) 3.91
Nuclear domain 10 as preexisting potential replication start sites of herpes simplex virus type-1. Virology (1996) 3.62
Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science (1991) 3.57
Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins. Oncogene (1999) 3.41
Predominant immediate-early transcripts of human cytomegalovirus AD 169. J Virol (1984) 3.15
Nuclear domain 10, the site of DNA virus transcription and replication. Bioessays (1998) 3.13
PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. J Virol (2006) 3.03
PML protein isoforms and the RBCC/TRIM motif. Oncogene (2001) 2.99
Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption. J Virol (1999) 2.87
Defective growth correlates with reduced accumulation of a viral DNA replication protein after low-multiplicity infection by a human cytomegalovirus ie1 mutant. J Virol (1998) 2.86
The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells. J Virol (1997) 2.83
Human cytomegalovirus immediate early interaction with host nuclear structures: definition of an immediate transcript environment. J Cell Biol (1997) 2.70
The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE1. Exp Cell Res (1996) 2.69
Interaction of SP100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment. Proc Natl Acad Sci U S A (1998) 2.59
Sequestration and inhibition of Daxx-mediated transcriptional repression by PML. Mol Cell Biol (2000) 2.59
DNA viruses and viral proteins that interact with PML nuclear bodies. Oncogene (2001) 2.57
A rapid microneutralization assay for the measurement of neutralizing antibody reactive with human cytomegalovirus. J Virol Methods (1989) 2.53
ND10 components relocate to sites associated with herpes simplex virus type 1 nucleoprotein complexes during virus infection. J Virol (2005) 2.36
Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl Acad Sci U S A (2005) 2.34
Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot. Oncogene (2001) 2.33
Daxx and histone deacetylase II associate with chromatin through an interaction with core histones and the chromatin-associated protein Dek. J Cell Sci (2002) 2.30
The function of PML in p53-dependent apoptosis. Nat Cell Biol (2000) 2.24
IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis. J Immunol (1992) 2.24
Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body. Proc Natl Acad Sci U S A (1998) 2.21
Disruption of PML subnuclear domains by the acidic IE1 protein of human cytomegalovirus is mediated through interaction with PML and may modulate a RING finger-dependent cryptic transactivator function of PML. Mol Cell Biol (1998) 2.21
Covalent modification of PML by the sentrin family of ubiquitin-like proteins. J Biol Chem (1998) 2.15
Chromatin components as part of a putative transcriptional repressing complex. Proc Natl Acad Sci U S A (1998) 2.14
Induction of the PML protein by interferons in normal and APL cells. Leukemia (1995) 2.05
Cell cycle regulation of PML modification and ND10 composition. J Cell Sci (1999) 2.04
A role for PML and the nuclear body in genomic stability. Oncogene (1999) 1.97
Covalent modification of the transactivator protein IE2-p86 of human cytomegalovirus by conjugation to the ubiquitin-homologous proteins SUMO-1 and hSMT3b. J Virol (2000) 1.91
Disruption of PML-associated nuclear bodies mediated by the human cytomegalovirus major immediate early gene product. J Gen Virol (1998) 1.87
Analysis of proteins encoded by IE regions 1 and 2 of human cytomegalovirus using monoclonal antibodies generated against recombinant antigens. Virology (1993) 1.83
Functional interaction between the pp71 protein of human cytomegalovirus and the PML-interacting protein human Daxx. J Virol (2002) 1.83
Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling. Proc Natl Acad Sci U S A (1999) 1.82
Daxx-mediated accumulation of human cytomegalovirus tegument protein pp71 at ND10 facilitates initiation of viral infection at these nuclear domains. J Virol (2002) 1.81
Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection. Virology (2000) 1.72
The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases. Mol Cell Biol (2001) 1.70
Differences in cell-type-specific blocks to immediate early gene expression and DNA replication of human, simian and murine cytomegalovirus. J Gen Virol (1988) 1.70
A novel transferable nuclear export signal mediates CRM1-independent nucleocytoplasmic shuttling of the human cytomegalovirus transactivator protein pUL69. EMBO J (2001) 1.55
The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body. J Cell Biol (2001) 1.54
Role of the cellular protein hDaxx in human cytomegalovirus immediate-early gene expression. J Gen Virol (2006) 1.52
The UL69 transactivator protein of human cytomegalovirus interacts with DEXD/H-Box RNA helicase UAP56 to promote cytoplasmic accumulation of unspliced RNA. Mol Cell Biol (2006) 1.50
An in vitro model for the regulation of human cytomegalovirus latency and reactivation in dendritic cells by chromatin remodelling. J Gen Virol (2005) 1.48
A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling. Proc Natl Acad Sci U S A (2006) 1.43
Recombinant green fluorescent protein-expressing human cytomegalovirus as a tool for screening antiviral agents. Antimicrob Agents Chemother (2000) 1.37
Daxx silencing sensitizes cells to multiple apoptotic pathways. Mol Cell Biol (2003) 1.35
Deletion of open reading frame UL26 from the human cytomegalovirus genome results in reduced viral growth, which involves impaired stability of viral particles. J Virol (2006) 1.25
Nuclear localization but not PML protein is required for incorporation of the papillomavirus minor capsid protein L2 into virus-like particles. J Virol (2004) 1.08
PML interacts with Myc, and Myc target gene expression is altered in PML-null fibroblasts. Oncogene (2005) 1.06
Human neuron-committed teratocarcinoma NT2 cell line has abnormal ND10 structures and is poorly infected by herpes simplex virus type 1. J Virol (2001) 0.96
SP100B is a repressor of gene expression. J Cell Biochem (2005) 0.89
Nuclear signalling by tumour-associated antigen EpCAM. Nat Cell Biol (2009) 4.05
PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. J Virol (2006) 3.03
Functional interaction between the pp71 protein of human cytomegalovirus and the PML-interacting protein human Daxx. J Virol (2002) 1.83
New insights into the role of the subnuclear structure ND10 for viral infection. Biochim Biophys Acta (2008) 1.82
Cellular p32 recruits cytomegalovirus kinase pUL97 to redistribute the nuclear lamina. J Biol Chem (2005) 1.77
Nuclear domain 10 components promyelocytic leukemia protein and hDaxx independently contribute to an intrinsic antiviral defense against human cytomegalovirus infection. J Virol (2007) 1.61
The antiviral activities of artemisinin and artesunate. Clin Infect Dis (2008) 1.55
The UL69 transactivator protein of human cytomegalovirus interacts with DEXD/H-Box RNA helicase UAP56 to promote cytoplasmic accumulation of unspliced RNA. Mol Cell Biol (2006) 1.50
The protein kinase pUL97 of human cytomegalovirus interacts with and phosphorylates the DNA polymerase processivity factor pUL44. Virology (2003) 1.38
Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron. Free Radic Biol Med (2004) 1.37
Antiviral activity of artesunate towards wild-type, recombinant, and ganciclovir-resistant human cytomegaloviruses. J Mol Med (Berl) (2001) 1.33
Sox10 is an active nucleocytoplasmic shuttle protein, and shuttling is crucial for Sox10-mediated transactivation. Mol Cell Biol (2002) 1.30
Intrinsic cellular defense mechanisms targeting human cytomegalovirus. Virus Res (2010) 1.26
Deletion of open reading frame UL26 from the human cytomegalovirus genome results in reduced viral growth, which involves impaired stability of viral particles. J Virol (2006) 1.25
Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation. Clin Infect Dis (2008) 1.23
The human cytomegalovirus regulatory protein UL69 and its effect on mRNA export. Front Biosci (2008) 1.21
Identification of the ATP-binding site in the terminase subunit pUL56 of human cytomegalovirus. Nucleic Acids Res (2003) 1.19
B cell repertoire analysis identifies new antigenic domains on glycoprotein B of human cytomegalovirus which are target of neutralizing antibodies. PLoS Pathog (2011) 1.16
A nonconventional nuclear localization signal within the UL84 protein of human cytomegalovirus mediates nuclear import via the importin alpha/beta pathway. J Virol (2003) 1.14
Protein kinase inhibitors of the quinazoline class exert anti-cytomegaloviral activity in vitro and in vivo. Antiviral Res (2008) 1.14
The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo. Antiviral Res (2005) 1.14
Direct targeting of human cytomegalovirus protein kinase pUL97 by kinase inhibitors is a novel principle for antiviral therapy. J Gen Virol (2002) 1.14
Human cytomegalovirus tegument proteins ppUL82 (pp71) and ppUL35 interact and cooperatively activate the major immediate-early enhancer. J Virol (2004) 1.11
RNA-binding of the human cytomegalovirus transactivator protein UL69, mediated by arginine-rich motifs, is not required for nuclear export of unspliced RNA. Nucleic Acids Res (2006) 1.09
Human cytomegalovirus immediate-early gene expression is restricted by the nuclear domain 10 component Sp100. J Gen Virol (2011) 1.05
Interplay between Herpesvirus Infection and Host Defense by PML Nuclear Bodies. Viruses (2009) 1.03
Evidence for a dual antiviral role of the major nuclear domain 10 component Sp100 during the immediate-early and late phases of the human cytomegalovirus replication cycle. J Virol (2011) 1.03
Multimerization of human cytomegalovirus regulatory protein UL69 via a domain that is conserved within its herpesvirus homologues. J Gen Virol (2007) 1.02
Functional reorganization of promyelocytic leukemia nuclear bodies during BK virus infection. MBio (2011) 1.02
Cytomegaloviral protein kinase pUL97 interacts with the nuclear mRNA export factor pUL69 to modulate its intranuclear localization and activity. J Gen Virol (2009) 1.02
Cyclin-dependent Kinases Phosphorylate the Cytomegalovirus RNA Export Protein pUL69 and Modulate Its Nuclear Localization and Activity. J Biol Chem (2009) 1.01
Human cytomegalovirus UL84 protein contains two nuclear export signals and shuttles between the nucleus and the cytoplasm. J Virol (2006) 1.00
Recruitment of human cytomegalovirus immediate-early 2 protein onto parental viral genomes in association with ND10 in live-infected cells. J Virol (2007) 0.99
Proteasome inhibitor MG132 blocks viral DNA replication and assembly of human cytomegalovirus. FEBS Lett (2008) 0.98
Why are we where we are? Understanding replication origins and initiation sites in eukaryotes using ChIP-approaches. Chromosome Res (2010) 0.98
Herpesvirus saimiri antagonizes nuclear domain 10-instituted intrinsic immunity via an ORF3-mediated selective degradation of cellular protein Sp100. J Virol (2012) 0.96
PML promotes MHC class II gene expression by stabilizing the class II transactivator. J Cell Biol (2012) 0.95
Synergistic induction of intercellular adhesion molecule-1 by the human cytomegalovirus transactivators IE2p86 and pp71 is mediated via an Sp1-binding site. J Gen Virol (2003) 0.94
Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantation. Antiviral Res (2011) 0.91
In vitro evaluation of the activities of the novel anticytomegalovirus compound AIC246 (letermovir) against herpesviruses and other human pathogenic viruses. Antimicrob Agents Chemother (2011) 0.91
Importance of covalent and noncovalent SUMO interactions with the major human cytomegalovirus transactivator IE2p86 for viral infection. J Virol (2009) 0.91
The unique antiviral activity of artesunate is broadly effective against human cytomegaloviruses including therapy-resistant mutants. Antiviral Res (2011) 0.91
Molecular targets for antiviral therapy of cytomegalovirus infections. Future Microbiol (2009) 0.90
RICK activates a NF-kappaB-dependent anti-human cytomegalovirus response. J Biol Chem (2003) 0.89
Downregulation of the cellular adhesion molecule Thy-1 (CD90) by cytomegalovirus infection of human fibroblasts. J Gen Virol (2004) 0.89
Insertion of an EYFP-pp71 (UL82) coding sequence into the human cytomegalovirus genome results in a recombinant virus with enhanced viral growth. J Virol (2008) 0.89
Novel chemical class of pUL97 protein kinase-specific inhibitors with strong anticytomegaloviral activity. Antimicrob Agents Chemother (2004) 0.88
ABA-responsive RNA-binding proteins are involved in chloroplast and stromule function in Arabidopsis seedlings. Planta (2006) 0.88
General blockade of human cytomegalovirus immediate-early mRNA expression in the S/G2 phase by a nuclear, Daxx- and PML-independent mechanism. J Gen Virol (2011) 0.87
Mapping of a self-interaction domain of the cytomegalovirus protein kinase pUL97. J Gen Virol (2007) 0.86
Recruitment of cyclin-dependent kinase 9 to nuclear compartments during cytomegalovirus late replication: importance of an interaction between viral pUL69 and cyclin T1. J Gen Virol (2011) 0.85
Profiling of the kinome of cytomegalovirus-infected cells reveals the functional importance of host kinases Aurora A, ABL and AMPK. Antiviral Res (2013) 0.84
The latent origin of replication of Epstein-Barr virus directs viral genomes to active regions of the nucleus. J Virol (2009) 0.82
Small ubiquitin-related modifier (SUMO) pathway-mediated enhancement of human cytomegalovirus replication correlates with a recruitment of SUMO-1/3 proteins to viral replication compartments. J Gen Virol (2013) 0.82
Efficient and tightly regulated expression systems for the human cytomegalovirus major transactivator protein IE2p86 in permissive cells. Virus Res (2002) 0.81
The cellular DExD/H-box RNA-helicases UAP56 and URH49 exhibit a CRM1-independent nucleocytoplasmic shuttling activity. PLoS One (2011) 0.80
Assessment of drug candidates for broad-spectrum antiviral therapy targeting cellular pyrimidine biosynthesis. Antiviral Res (2013) 0.80
Human cytomegalovirus pp71 stimulates major histocompatibility complex class i presentation of IE1-derived peptides at immediate early times of infection. J Virol (2013) 0.79
Identification of inhibitors for a virally encoded protein kinase by 2 different screening systems: in vitro kinase assay and in-cell activity assay. J Biomol Screen (2005) 0.79
Murine cytomegalovirus infection leads to increased levels of transplant arteriosclerosis in a murine aortic allograft model. Transplantation (2010) 0.79
Rag2-/- gamma-chain-/- mice as hosts for human vessel transplantation and allogeneic human leukocyte reconstitution. Transpl Immunol (2010) 0.79
Structural requirements for nuclear localization of GCMa/Gcm-1. FEBS Lett (2003) 0.79
Perinuclear localization of the HIV-1 regulatory protein Vpr is important for induction of G2-arrest. Virology (2012) 0.78
Nucleocytoplasmic shuttling and CRM1-dependent MHC class I peptide presentation of human cytomegalovirus pp65. Med Microbiol Immunol (2012) 0.77
Methods to study the nucleocytoplasmic transport of macromolecules with respect to their impact on the regulation of human cytomegalovirus gene expression. Methods Mol Biol (2014) 0.76
Identification of novel allosteric modulators for the G-protein coupled US28 receptor of human cytomegalovirus. Bioorg Med Chem Lett (2011) 0.76